Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adjuvants recognized by toll-like receptors inhibit the induction of polarized type 2 T cell responses by natural attachment (G) protein of respiratory syncytial virus.

Vaccine - 1 Oct 2003

Hancock Gerald E, Heers Kristen M, Pryharski Karin S, Smith Jason D, Tiberio Lorrie

Abstract excerpt

Immunization with native fusion (F) protein from respiratory syncytial virus (RSV) adsorbed to alum adjuvant generates greater than fourfold rises in serum neutralizing antibody titers in approximately 50% of seropositive humans. Using BALB/c mice we demonstrate herein that enhanced neutralization titers and accelerated clearance of virus from the lungs after challenge are possible if the attachment (G)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adjuvants, Immunologic
Share to Eosinophils

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Granulocytes

Share to Respiratory Syncytial Virus, Human

Share to Thrombopoietin

Share to Toll-Like Receptor 2

Share to Toll-Like Receptor 3

Share to Viral Plaque Assay

Source

Identifiers

PMID: 14505917
DOI: 10.1016/s0264-410x(03)00482-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adjuvants recognized by toll-like receptors inhibit the induction of polarized type 2 T cell responses by natural attachment (G) protein of respiratory syncytial virus.PMID 14505917Read ↗

Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine DevelopmentSemantic proximity Read ↗

The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine CandidateSemantic proximity Read ↗

Prime-pull immunization of mice with a BcfA-adjuvanted vaccine elicits mucosal immunity and prevents SARS CoV-2 infection and pathologySemantic proximity Read ↗

Protective antigenic sites identified in respiratory syncytial virus fusion protein reveals importance of p27 domainSemantic proximity Read ↗

Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells.Semantic proximity Read ↗

The pulmonary immune response of Balb/c mice vaccinated with the fusion protein of respiratory syncytial virus.Semantic proximity Read ↗

Immune responses to the nonglycosylated ectodomain of respiratory syncytial virus attachment glycoprotein mediate pulmonary eosinophilia in inbred strains of mice with different MHC haplotypes.Semantic proximity Read ↗

A Pan-Pneumovirus vaccine based on immunodominant epitopes of the fusion proteinSemantic proximity Read ↗

Rational design of respiratory syncytial virus dimeric F-subunit vaccines in protein and mRNA formsSemantic proximity Read ↗

A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism.Semantic proximity Read ↗

A safe and effective mucosal RSV vaccine in mice consisting of RSV phosphoprotein and flagellin variant.Semantic proximity Read ↗

A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virusSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.